ABVC BIOPHARMA, INC. Operating Lease, Liability, Noncurrent
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Noncurrent $1.41M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $1.51M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $1.60M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $164.07K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $1.41M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.51M 10-Q · filed 2026-05-18 |
| 2025-12-31 | $1.60M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $164.07K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $177.13K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $166.99K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $236.81K 10-Q/A · filed 2026-03-03 |
| 2024-09-30 | $142.20K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $228.80K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $318.15K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $407.46K 10-K · filed 2025-04-15 |
| 2023-09-30 | $507.15K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $609.14K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $711.43K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $791.83K 10-K · filed 2024-03-13 |
| 2022-09-30 | $880.18K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $944.27K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.03M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.12M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.21M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.30M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.38M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.46M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.53M 10-Q · filed 2020-11-17 |
| 2020-06-30 | $173.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $179.99K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $235.56K 10-K · filed 2021-03-16 |
| 2019-09-30 | $106.40K 10-Q · filed 2019-11-18 |
| 2019-06-30 | $170.99K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $239.65K 10-Q · filed 2019-05-28 |